DEFER
发表于 2025-3-25 04:15:15
http://reply.papertrans.cn/83/8285/828464/828464_21.png
ARBOR
发表于 2025-3-25 10:56:05
http://reply.papertrans.cn/83/8285/828464/828464_22.png
Barter
发表于 2025-3-25 13:59:57
http://reply.papertrans.cn/83/8285/828464/828464_23.png
使尴尬
发表于 2025-3-25 18:07:08
http://reply.papertrans.cn/83/8285/828464/828464_24.png
征服
发表于 2025-3-25 23:01:59
http://reply.papertrans.cn/83/8285/828464/828464_25.png
出价
发表于 2025-3-26 03:07:55
http://reply.papertrans.cn/83/8285/828464/828464_26.png
体贴
发表于 2025-3-26 04:22:39
978-3-319-83438-2Springer International Publishing Switzerland 2016
以烟熏消毒
发表于 2025-3-26 09:43:04
Resistance to Tyrosine Kinase Inhibitors978-3-319-46091-8Series ISSN 2196-5501 Series E-ISSN 2196-551X
寒冷
发表于 2025-3-26 16:11:07
http://reply.papertrans.cn/83/8285/828464/828464_29.png
Innocence
发表于 2025-3-26 17:04:10
Indications for Tyrosine Kinase Inhibitors in the Treatment of Solid Tumors,nical trials showed survival benefit, setting new treatment indications. Moreover, new molecules are being developed targeting resistance mechanisms such as acquired mutations or feedback mechanisms of the upregulated signaling pathway. The available TKIs and their indications of use through clinical trials are listed and discussed.